Asset
ATOLTIVIMAB
Regeneron Pharmaceuticals Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (0)
No records yet.
FDA applications (1)
| Application | Type | Applicant |
|---|---|---|
| BLA 761169 | BLA | Regeneron Pharmaceuticals, Inc. |
Marketed products (2)
- INMAZEB
- Inmazeb